Brief: DSS Inc - Impact BioMedical Develops Quantum Antihistamine
26/07/2022 14:13
July 26 (Reuters) - DSS Inc DSS.A :
* DSS INC - IMPACT BIOMEDICAL DEVELOPS QUANTUM ANTIHISTAMINE
Source text for Eikon: ID:nGNXbN9VXm
Further company coverage: DSS.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DSS
See all newsBrief: Dss Withdraws S-1 Registration Statement With SEC
Brief: Dss Reports Going Concern Audit Opinion In 2025 10-K Filing
Brief: Dss Inc Actively Evaluating Acquisition Opportunities Within Folding Carton Space
Brief: Dss, Inc. Announces Pricing Of $1.0 Million Underwritten Public Offering
Brief: DSS’s Subsidiary, Impact Biomedical, Announces Strategic Merger